login
login

Europe Daily Bulletin No. 10776

1 February 2013
ECONOMY - FINANCE - BUSINESS / (ae) competition
J&J and Novartis delayed entry of generic painkiller in Netherlands

Brussels, 31/01/2013 (Agence Europe) - On 31 January 2013, the European Commission sent a Statement of Objections to two pharmaceutical companies, Johnson & Johnson (J&J, United States) and Novartis (Switzerland) accusing them of delaying by 17 months the entry onto the Dutch market of a generic painkiller that is a cheaper alternative to J&J's Fentanyl, also accusing them of keeping the price of Fentanyl artificially high in the Dutch market through an agreement between the two companies'...

Contents

A LOOK BEHIND THE NEWS
ECONOMY - FINANCE - BUSINESS
SECTORAL POLICIES
EXTERNAL ACTION